期刊文献+

耐甲氧西林金黄色葡萄球菌流行病学分析及耐药性研究 被引量:4

Epidemiological Analysis of Methicillin-resistant Staphylococcus aureus and Study on Its Drug Resistance
原文传递
导出
摘要 目的了解近5年来邵阳市中心医院耐甲氧西林金黄色葡萄球菌(MRSA)感染的流行病学及耐药情况。方法对该院2006年1月-2010年12月收集的10 215份不同标本培养结果进行回顾性统计分析,分析MRSA检出率及药敏情况。结果在10 215份不同标本中,检出耐甲氧西林菌株1 195株,占检出细菌的18.45%(1 195/6 476),其分离率有逐年增长的趋势。MRSA对临床常用多种抗生素的耐药率为80%以上,对万古霉素及替考拉宁的敏感率为100%。结论 MRSA发生率呈逐年上升趋势,且呈现多重耐药,应加强抗菌药物的合理应用,减少MRSA耐药的发生。 Objective To investigate the epidemiology of methicillin- resistant Staphylococcus aureus (MRSA) infection and its drug resistance, which isolated from the Central Hospital of Shaoyang City in the recent five years. Methods The bacterial culture results of 10,215 different specimens from inpatients of the hospital from January 2006 to December 2010 were retrospectively analyzed. The detection rate of MRSA and its drug resistance were also analyzed. Results Altogether 1,195 strains of MRSA were i^lated from 10,215 different specimens, accounted for 18.45 % of the detected bacteria (1,195/6,476), and the isolation rate of MRSA was increasing year by year. The resistant rates of MRSA against commonly used antibiotics were above 80%, but the sensitive rates of MRSA to vancomycin and teicoplanin were both 100%. Conclusions The incidence of MRSA infection shows an upward trend within these years, and moreover, its antibiotic resistance is multiple. We should strengthen the rational use of antibiotics .so as to reduce the occurrence of drug resistance of MRSA.
出处 《实用预防医学》 CAS 2012年第8期1228-1229,共2页 Practical Preventive Medicine
关键词 耐甲氧西林金黄色葡萄球菌 流行病学 耐药性 MRSA Epidemiology Drug resistance
  • 相关文献

参考文献8

二级参考文献27

共引文献229

同被引文献36

  • 1马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 2马筱玲.万古霉素敏感性减低的金黄色葡萄球菌[J].中华检验医学杂志,2004,27(9):620-622. 被引量:18
  • 3张川,郑碧霞,谢晖,江利东,程金川,卫琦,李晓玉.综合监护室革兰阳性菌医院感染的调查分析[J].中华医院感染学杂志,2007,17(7):807-808. 被引量:4
  • 4Reddy P, Chadaga S, Noskin GA. Antibiotic considerations in the treatment of muhidrug - resistent (MDR) pathogens : a case - base- dreview[J]. J Hosp Med, 2009, 4(6) : 8 -15.
  • 5Tenover FC, Moellering RC Jr. The rationale for revising the clini- cal and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus [ J ]. Clin Infect Dis, 2007, 44(9) : 1208 -1215.
  • 6Khurshid MA, Chou T, Carey R, et al. Staphylococcus aureus with reduced susceptibility to Vancomycin - Illinois, 1999 [ J ]. Morb Mortal Wkly Rep, 2000, 48(51 ) : 1165 - 1167.
  • 7CDC. Vancomycin resistant Staphylococcus aureus, New Yoek, 2004 [Jl. Morb Mortal Wkly Rep, 2004, 5(15) : 322 -323.
  • 8Sun W, Chen H, Liu Y, et al. Prevalence and characterization of heterogeneous Vancomycin - interaediate Staphylococctts aureus iso- lates fron 14 cities in China[J]. Antimicrob Agents Chemocher, 2009, 53(9): 6342-6349.
  • 9Saha B, Singh AK, Ghosh A, et al. Identificatio and characteriza- tion of a Vancomycin resistant Staphylococcus aureus isolated from Kotkota(South Asia) [J]. J Med Micolbiol, 2008, 57( 1 ) : 72 - 79.
  • 10李娅,吴绪伟,黄云昆,肖谊.革兰阳性菌流行及耐药情况分析[J].中国医院用药评价与分析,2009,9(2):118-120. 被引量:3

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部